Anthrax Vaccine and Public Health Policy
- 1 November 2007
- journal article
- review article
- Published by American Public Health Association in American Journal of Public Health
- Vol. 97 (11) , 1945-1951
- https://doi.org/10.2105/ajph.2006.102749
Abstract
The Centers for Disease Control and Prevention has classified Bacillus anthracis, the causative organism of anthrax, as a category A potential bioterrorism agent. There are critical shortcomings in the US anthrax vaccine program. Rather than depending on the private sector, the government must assume direct production of anthrax vaccine. The development of a capacity capable of preemptive immunization of the public against anthrax should be considered.Keywords
This publication has 39 references indexed in Scilit:
- Forensic Application of Microbiological Culture Analysis To Identify Mail Intentionally Contaminated with Bacillus anthracis SporesApplied and Environmental Microbiology, 2006
- Autoimmune Folate Deficiency and the Rise and Fall of “Horror Autotoxicus”New England Journal of Medicine, 2005
- Public health vaccination policies for containing an anthrax outbreakNature, 2004
- Bioterrorism and compulsory vaccinationBMJ, 2004
- Anthrax inhalation and lethal human infectionThe Lancet, 2002
- Molecular Investigation of the Aum Shinrikyo Anthrax Release in Kameido, JapanJournal of Clinical Microbiology, 2001
- Vaccines for Biodefense: A System in DistressScience, 2001
- Historical Trends Related to Bioterrorism: An Empirical AnalysisEmerging Infectious Diseases, 1999
- Nuclear Blindness: An Overview of the Biological Weapons Programs of the Former Soviet Union and IraqEmerging Infectious Diseases, 1999
- Expression of cereolysine AB genes in Bacillus anthracis vaccine strain ensures protection against experimental hemolytic anthrax infectionVaccine, 1997